Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease

NCT00006488 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: recombinant-methionyl human glial cell line-derived neurotrophic factor

Sponsor

National Center for Research Resources (NCRR)